Published: Jan 07, 2026
•ID: 4402209
•129 PagesJieyu Anshen
Granules
Jieyu Anshen Granules Market Shows Incredible Growth Soon
Global Jieyu Anshen Granules Market is segmented by Application (Anxiety Disorders, Insomnia, Depression Support, Stress Management, Clinical TCM Use), Type (Standard Formula, Modified Formula, Pediatric, Adult, Sugar-free), and Geography (North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
Report ID:
HTF4402209
Published:
CAGR:
11.60%
Market Size (2025):
$1.20 billion
Forecast (2033):
$2.85 billion
Pricing
Report Overview
Industry Overview
The Jieyu Anshen Granules is at USD 1.20 billion in 2025 and is expected to reach 2.85 billion by 2033. The Jieyu Anshen Granules is driven by increasing demand in end-use industries, technological advancements, research and development (R&D), economic growth, and global trade.
Jieyu Anshen Granules are traditional Chinese medicinal formulations used to relieve anxiety, insomnia, depression, and emotional imbalance. Composed of standardized herbal extracts, they aim to regulate mood, calm the nervous system, and restore psychological balance. Increasing acceptance of complementary medicine and demand for natural mental health solutions are driving their global market growth.
Source: HTF Market Intelligence (HTF MI)
Competitive landscape
The companies highlighted in this profile were selected based on insights from primary experts and an evaluation of their market penetration, product offerings, and geographical reach:
- • Tasly (China)
- • Tongrentang (China)
- • Yunnan Baiyao (China)
- • Shineway (China)
- • Hutchison Whampoa (Hong Kong)
- • China Resources (China)
- • Buchang Pharma (China)
- • Livzon (China)
- • Kangmei (China)
- • Sanofi (France)
- • Harbin Pharma (China)
- • Guangzhou Pharma (China)
- • Taiji Group (China)
- • Yangtze River Pharma (China)
- • Joincare (China)
Market Drivers:
Challenge Factor:
Opportunities:
Important Trend:
Regulatory Framework
- • Compliance focuses on safety
Regional Insight
The Asia-Pacific leads the market share, largely due to rising consumption, a growing population, and strong economic momentum that boosts demand. In contrast, the Asia-Pacific is emerging as the fastest-growing area, driven by rapid infrastructure development, the expansion of industrial sectors, and heightened consumer demand, making it a critical factor for future market growth. The regions covered in the report are
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Loading map...
Regional Analysis
- • Demand concentrates in North America and Europe for premium compliance and early adoption; Asia-Pacific drives volume via cost-competitive supply and fast scaling. Middle East & Africa and Latin America grow through distributor channels and public programs; localization and after-sales networks decide share.——
Market Segmentation
Segmentation by Type
- • Standard Formula
- • Modified Formula
- • Pediatric
- • Adult
- • Sugar-free
Segmentation by Application
- • Anxiety Disorders
- • Insomnia
- • Depression Support
- • Stress Management
- • Clinical TCM Use
Key Development Activities
Market Entropy
- • Mar 2025 – TCM Health developed Jieyu Anshen herbal granules standardized for mood stabilization and sleep-support formulations.
Merger & Acquisition
- • In February 2024
Regulatory Landscape
- • Compliance focuses on safety
Patent Analysis
- • Patent activity clusters around formulations
Investment and Funding Scenario
- • Funding favors scalable pilots
Report Details
| Report Features | Details |
| Base Year | 2025 |
| Based Year Market Size (2025) | 1.20 billion |
| Historical Period | 2020 to 2025 |
| CAGR (2025 to 2033) | 11.60% |
| Forecast Period | 2026 to 2033 |
| Forecasted Period Market Size (2033) | 2.85 billion |
| Scope of the Report | Standard Formula, Modified Formula, Pediatric, Adult, Sugar-free, Anxiety Disorders, Insomnia, Depression Support, Stress Management, Clinical TCM Use |
| Companies Covered | Tasly (China), Tongrentang (China), Yunnan Baiyao (China), Shineway (China), Hutchison Whampoa (Hong Kong), China Resources (China), Buchang Pharma (China), Livzon (China), Kangmei (China), Sanofi (France), Harbin Pharma (China), Guangzhou Pharma (China), Taiji Group (China), Yangtze River Pharma (China), Joincare (China) |
| Customization Scope | 15% Free Customization |
| Delivery Format | PDF and Excel through Email |
Research Methodology
The research methodology involves several key steps to ensure comprehensive and accurate insights. First, the objectives of the research are clearly defined, focusing on aspects such as market size, growth trends, and competitive dynamics. Data collection is conducted through both primary and secondary methods. Primary research includes interviews with industry experts, surveys, and focus groups to gather firsthand information, while secondary research involves analyzing existing reports, government publications, and company filings.
The collected data is then subjected to rigorous analysis, with quantitative methods used to evaluate market size and trends and qualitative methods applied to understand industry dynamics and consumer behavior. Findings are compiled into a detailed report featuring key insights, data visualizations, and strategic recommendations. Validation is achieved through data verification and peer reviews to ensure accuracy.
Finally, the research concludes with actionable insights and recommendations, along with suggestions for future studies to address emerging trends and gaps. This methodology provides a structured approach to understanding the {keywords} and guiding strategic decisions.